Suresign Finecare
CEA Rapid Quantitative Test
Finecare CEA (Carcino-Embryonic Antigen) test for the monitoring of carcinoma
The Finecare CEA Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare Plus Analyser for the quantitative determination of CEA in human whole blood, serum or plasma. The test is used as an aid in the evaluation of therapeutic efficiency, prognosis & recurrence monitoring for carcinoma.
Easy to use
- No analyser calibration required.
- Virtually maintenance free analyser.
- Tests only require a small aliquot of venous blood, serum or plasma.
- Familiar cassette technology.
- Rapid 15 minute read time.
Efficient
- 25 test kit for low usage sites.
- Room temperature storage.
- Long shelf life.
- Assay Range: 1-500ng/ml.
- Detection Limit (Analytical Sensitivity): 1ng/mL.
- All tests provide quantitative results.
- Wide range of tests are available on the Finecare Plus Analyser.
Reliable
- Laboratory standard results.
- Automated reading eliminates subjectivity & administrative errors.
- Simple technology = reliable technology.
Demonstrations available Book Now
Downloads
Find out more about the company behind our brands. From Suresign to Checkpoint CIGA Healthcare is one of the UK’s leaders in Rapid Test Diagnostics.
Visit
Discover our OTC range of products for home testing. From pregnancy to blood pressure Suresign OTC is one of the UK’s leading rapid diagnostic brands.
Visit
Learn more about how Suresign are tackling the ever rising subject of diabetes. Includes information on our diabetes testing & advice on how to manage your condition.
Visit